Special Volunteers

Eric Bernhard, Ph.D.
Martin Brechbiel, Ph.D.
David Pistenmaa, M.D., Ph.D.
Anil Srivastava
Rosemary Wong, Ph.D.

Eric Bernhard, Ph.D.

Professional Background

• Program Director in RRP for 8 years; Chief Radiotherapy Development Branch; retired in 2018

• MRC Senior Investigator; Oxford University

• Research Associate Professor; University of Pennsylvania

• Currently scientific consultant and editor

Current Projects for RRP

• Provide advice on charged particle programs and other radiation biology activities as requested by RRP

• Review and edit RRP documents and presentations as requested

Martin Brechbiel, Ph.D.

• Senior Investigator at NCI with 33 years of experience in bifunctional chelating agents, conjugation chemistry, use of radionuclides (α, β-, β+, γ, Auger emitters) for imaging and targeted therapy with a special emphasis on targeted therapy.

• Employee of the Radiation Oncology Branch, NCI and retired to Emeritus status in 2017.

Current Projects for RRP

• Provides advice when requested on bifunctional chelating agents, conjugation chemistry, use of radionuclides (α, β-, β+, γ, Auger emitters) for imaging and targeted therapy as requested by RRP.

David Pistenmaa, M.D., Ph.D.

Professional Background

• Served 9 years in the U.S. Army Corps of Engineers, which included a two year tour of duty in the Army Nuclear Power Program at the Atomic Energy Agency (now DOE) in Germantown, MD.

• Radiation Oncologist for 45 years with long-term interest in charged particle radiation therapy; retired in March 2015

• Employee of NCI when the Radiation Oncology Branch became the Radiation Research Program in the Division of Cancer Treatment (now DCTD) in 1982.

Current Projects for RRP

• Provide advice when requested on charged particle programs, other radiation therapy, biology and physics activities as assigned by RRP.

Anil Srivastava

Professional Background

• President of the Open Health Systems Laboratory

• Program Lead for ICTBioMed: International Consortium for Technology in Biomedicine and the Rescuing and Repurposing Drugs for Cancer (RRDC) Initiative

• Senior Advisor for Life Sciences at Internet2

• Visiting Faculty at Tata Memorial Centre in Mumbai, India

Current Projects for RRP

• Indo-US research opportunities for Radiation Biology

• In silico fast throughput screening to identify radiosensitizers and inhibitors for cancer therapy

• Telesynergy®

• International cooperation and additional projects as assigned by the Radiation Research Program

Rosemary Wong, Ph.D.

Professional Background

• Radiation Biologist with over 25 years in vitro/in vivo laboratory experience investigating the combined use of hyperthermia and radiation to improve cancer therapy.

• Program Director overseeing RRP's Cancer Disparity Research Partnership (CDRP) program to address cancer disparities seen in various racial/ethnic and underserved populations in the US.

• Health Science Administrator/Program Director in RRP for 17 years; retired in 2016.

Current Projects for RRP

• Ongoing trainer for RRP staff on use of NIH/NCI databases to carry out job functions.

• Assist RRP staff on Oncology Outreach projects as needed.

• Projects as assigned by RRP.